Gene · 1540
Papers3,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer. | Clin Cancer Res | 2026 | 41603724 | PubTator, text mining | PubMed |
| An elevated level of the mRNA exporter Mex67-Mtr2 in nuclear mRNPs impairs nuclear mRNA export. | Nucleic Acids Res | 2026 | 41574433 | PubTator, text mining | PubMed |
| Severe leukemoid reaction and spontaneous tumor lysis syndrome in a young patient with undifferentiated Lynch syndrome-associated ovarian cancer. | Gynecol Oncol Rep | 2026 | 41567619 | PubTator, text mining | PubMed |
| Human donor islets coated with functionalized chitosan and alginate nanoscale layers can restore normoglycemia in diabetic mice. | Mater Today Bio | 2026 | 41560789 | PubTator, text mining | PubMed |
| Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directions. | Biologics | 2026 | 41551208 | PubTator, text mining | PubMed |
| Novel sporadic c.2687G>T (p.Gly896Val) CYLD mutation in multiple trichoepitheliomas. | An Bras Dermatol | 2026 | 41544310 | PubTator, text mining | PubMed |
| Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. | Commun Med (Lond) | 2026 | 41526458 | PubTator, text mining | PubMed |
| Neuromedin B and its receptor NMBR inhibit H9N2 infection. | Vet Microbiol | 2026 | 41242095 | PubTator, text mining | PubMed |
| Clinicopathologic and molecular characterization of a series of sporadic trichoblastic neoplasms. | Virchows Arch | 2026 | 41203975 | PubTator, text mining | PubMed |
| Thymus-like phenotype in benign lymphoepithelial neoplasms of salivary glands: clinicopathological and molecular characterization and reappraisal of relationship to non-sebaceous lymphadenoma. | Virchows Arch | 2026 | 40913630 | PubTator, text mining | PubMed |
| Integrative Molecular Analysis of Skin Tumors from Patients with CYLD Cutaneous Syndrome. | J Invest Dermatol | 2026 | 40412469 | PubTator, text mining | PubMed |
Genomic and transcriptomic characterization of gamma ray- and heavy-ion-induced precursor B-cell lymphomas in B6C3F1 mice: radiation-type-dependent interstitial chromosomal deletions at tumor-suppressor gene loci. | Carcinogenesis | 2025 | 41542965 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
| Advanced CYLD Cutaneous Syndrome (CCS) Treated With the Hedgehog Signaling Pathway Inhibitor Vismodegib Results in a Limited Clinical Response. | APMIS | 2025 | 41321185 | PubTator, text mining | PubMed |
| Effect of the double-application of one-step universal adhesives on bonding strength to bur-cut enamel. | BMC Oral Health | 2025 | 41310586 | PubTator, text mining | PubMed |
| Identification of biomarkers associated with SUMO modification in heart failure. | Medicine (Baltimore) | 2025 | 41189222 | PubTator, text mining | PubMed |
| Nucleotide-Binding Oligomerization Domain 2 in Signaling, Immunity, and Mycobacterial Infection. | Immun Inflamm Dis | 2025 | 41017210 | PubTator, text mining | PubMed |
| A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4. | Nat Commun | 2025 | 41006235 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| The tumor suppressor CYLD acts as a deubiquitinase for mTOR to constrain its activity. | bioRxiv | 2025 | 40950055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1540/papers?page=4